Literature DB >> 20932611

Clinical negligence and duty of candour.

Vinita Shekar1, Mark Singh, Kishore Shekar, Peter Brennan.   

Abstract

The Department of Health is considering imposing a legal duty of candour on health care providers to ensure that an apology and explanation are given to patients when errors occur during medical treatment. This aims to improve quality of care and reduce adverse events during medical treatment. We present the current system of clinical negligence and the future of medical ethics. We discuss relevant cases with regard to duty of candour, and highlight the existence of serious imbalances in which patients' rights and corresponding ethical duties of professionals predominate over the responsibilities of patients themselves. It is known that most adverse events arise because of multiple factors for which no individual should be blamed. To improve healthcare services there is a need for a system in which lessons can be learnt from mistakes, and services can be improved in the interest of patient safety, and for transparency in the broad principles on which the decisions are based within which clinical performance is supervised and monitored.
Copyright © 2010 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20932611     DOI: 10.1016/j.bjoms.2010.08.011

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  2 in total

1.  Ethical responsibility and treatment errors.

Authors:  J Blood
Journal:  Br Dent J       Date:  2014-01       Impact factor: 1.626

2.  Surveillance of antibiotic and analgesic use in the Oral Surgery Department of the University Dentistry Clinical Center of Kosovo.

Authors:  Naim R Haliti; Fehim R Haliti; Ferit K Koçani; Ali A Gashi; Shefqet I Mrasori; Valon I Hyseni; Samir I Bytyqi; Lumnije L Krasniqi; Ardiana F Murtezani; Shaip L Krasniqi
Journal:  Ther Clin Risk Manag       Date:  2015-10-01       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.